Abstract Glucagon-like-peptide-1 (GLP-1) agonists are an emerging class of medications used to manage type 2 diabetes mellitus (T2DM) and weight loss, with demonstrated efficacy in reducing hemoglobin A1c levels, body mass index, and adverse cardiovascular events
Experimental hyperlipidemia and the effect of NSAIDs
Gvenilir Satclarla Kolay letiim: Platform, gvenilir ve salam satclarla alarak kullanclarn alveri srecini gvenli hale getirir
The same receptor class that mediates circadian skin pigmentation response in mammals
Dysfunction of this process leads to the genetic disorders primary carnitine deficiency, carnitine palmitoyltransferase I deficiency, carnitine palmitoyltransferase II deficiency and carnitine-acylcarnitine translocase deficiency
Die amerikanische Akademie der Wissenschaft hlt 200 Mikrogramm tglich als Nahrungsergnzung fr sicher und angemessen